Correspondence 0001437749-22-029461 from BioCardia, Inc. (BCDA)
BioCardia, Inc.
Date: Dec. 20, 2022 · CIK: 0000925741 · Accession: 0001437749-22-029461
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268862
Letter
bcda20221220_corresp.htm
December 20, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Re:
BioCardia, Inc.
Registration Statement on Form S-3 (File No. 333-268862)
Acceleration Request
Requested Date: Thursday, December 22, 2022
Requested Time: 4:30 P.M. Eastern Standard Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
[Signature page follows]
Securities and Exchange Commission
December 20, 2022
Page 2
Sincerely,
BIOCARDIA, INC.
Show Raw Text
CORRESP 1 filename1.htm bcda20221220_corresp.htm December 20, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Re: BioCardia, Inc. Registration Statement on Form S-3 (File No. 333-268862) Acceleration Request Requested Date: Thursday, December 22, 2022 Requested Time: 4:30 P.M. Eastern Standard Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410. [Signature page follows] Securities and Exchange Commission December 20, 2022 Page 2 Sincerely, BIOCARDIA, INC. /s/ Peter Altman Peter Altman President and Chief Executive Officer Enclosures cc: David McClung, BioCardia, Inc. Michael J. Danaher, Brian Dillavou, and Austin D. March, Wilson Sonsini Goodrich & Rosati, P.C.